A group of Jewish and Israeli former students who have accused a Victorian high school of allowing racially-charged bullying have defeated a bid by the state government to adjourn evidence at trial after its silk was diagnosed with COVID-19.
A inquiry into former prime minister Scott Morrison’s appointment as shadow minister of five government portfolios has found the secret appointments “fundamentally undermined” the principles of responsible government.
Automotive electronics company Directed Electronics has largely prevailed in a five-year-old lawsuit alleging a former manager misappropriated company information and reaped $3.6 million in commissions through a secret side agreement with South Korean giant Hanhwa.
The Albanese government has removed provisions from sex harassment legislation that passed the senate on Friday which would have forced parties to bear their own costs in harassment litigation, after dozens of lawyers expressed “deep concern”.
The lead applicant in a class action on behalf of investors who sank $12.3 million into an allegedly fraudulent sports betting scheme run by convicted conman Peter Foster may drop the case after a partner in the scheme filed for bankruptcy.
The Australian Securities and Investments Commission has placed interim stop orders on two crypto funds distributed by Perpetual Investment Management Limited, citing the need to protect retail clients from investing in risky, volatile funds.
Car manufacturer Jaguar Land Rover has been hit with a class action alleging it misled drivers over vehicles fitted with defective diesel particulate filters.
A judge has questioned a tiered contingency fee arrangement in a proposed group costs order by the law firm running a shareholder class action against Crown, asking whether the lower-end percentages were “meaningless”.
Insurer Allianz has lost its bid to claw back millions in performance bonds provided to collapsed building company Probuild in relation to works at a $1 billion development in the Melbourne CBD.
Australian pharmaceutical company AUPharma has sued the international arm of Purdue, alleging it was wrongly granted patent extensions for several oxycodone products marketed as Targin.
For information on rights and reprints, contact subscriptions@lawyerly.com.au
